Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
58.65
-0.15 (-0.26%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Xenon Pharmaceuticals Market Cap
Xenon Pharmaceuticals has a market cap or net worth of $5.68 billion as of September 11, 2026. Its market cap has increased by 98.49% in one year.
Market Cap
5.68B
Enterprise Value
4.44B
1-Year Change
98.49%
Ranking
Category
Stock Price
$58.65
ChartMarket Cap Chart
Since November 5, 2014, Xenon Pharmaceuticals's market cap has increased from $142.20M to $5.68B, an increase of 3,894.16%. That is a compound annual growth rate of 36.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 5.68B | 63.99% |
| Dec 31, 2025 | 3.46B | 15.89% |
| Dec 31, 2024 | 2.99B | -0.83% |
| Dec 29, 2023 | 3.01B | 22.21% |
| Dec 30, 2022 | 2.47B | 53.02% |
| Dec 31, 2021 | 1.61B | 199.33% |
| Dec 31, 2020 | 538.40M | 58.77% |
| Dec 31, 2019 | 339.10M | 112.87% |
| Dec 31, 2018 | 159.30M | 213.58% |
| Dec 29, 2017 | 50.80M | -63.13% |
| Dec 30, 2016 | 137.80M | 19.20% |
| Dec 31, 2015 | 115.60M | -58.73% |
| Dec 31, 2014 | 280.10M | 96.98% |
| Nov 5, 2014 | 142.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 6.41B |
| Mirum Pharmaceuticals | 6.38B |
| Travere Therapeutics | 6.24B |
| Oruka Therapeutics | 6.12B |
| Dianthus Therapeutics | 5.94B |
| Cogent Biosciences | 5.80B |
| Ligand Pharmaceuticals | 5.67B |
| Erasca | 5.55B |